In both PANC1 and BxPC3 cells, the STOML2 antibody could also pull down PARL, which suggested that STOML2 could directly bind and stabilize PARL in pancreatic cancer cells (Fig. 4H, I). The gene discussed is STOML2; the disease is familial pancreatic carcinoma.